USPTO serial 90578850
EMBRACE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 19, 2023
- Examiner
- JAGANNATHAN, SIDDHARTH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EMBRACE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William E. Anderson
William E. Anderson CHRISTENSEN, FONDER, DARDI & HERBERT PLLC11322 86TH AVENUE NORTHMAPLE GROVE, MN 55369UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparations for embolization therapy in interventional radiology and oncology in the nature of implantable materials, namely, pliable, synthetic hydrogel; embolization therapy preparations; preparations for implantable hydrogel-based embolics, namely, pliable synthetic hydrogel; preparations for implantable surgical materials, namely, pliable, synthetic hydrogel; medical preparations for arterial embolectomy purposes; differentiated liquid embolic preparations; preparations for differentiated liquid embolics for surgical purposes; medical preparations for embolic devices for treating anomalies vasculature of the body; medical preparations for embolization therapy systems, namely, pliable synthetic hydrogel; medical preparations for interventional radiology, namely, interventional oncology and peripheral hemostasis in the nature of synthetic hydrogel based liquid embolics; medical preparations for vascular embolization procedures; medical preparations for vascular embolization, hemorrhage control, and peripheral hemostasis; surgical hydrogel precursors; surgical hydrogel precursors for kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; medical preparations used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; kits for use in medical and surgical procedures comprised of precursors that react to form a hydrogel when combined with each other and applicators therefore; embolic devices for vascular embolization, hemorrhage control, and peripheral hemostasis, namely, embolization therapy system, primarily featuring hydrogel precursors and applicator; kits for vascular embolization procedures, featuring hydrogel precursors and applicator | ACTIVE | Jul 1, 2023 |
| 010 | Medical apparatus and instruments for embolization in the nature of synthetic hydrogel based liquid embolics delivered through microcatheter systems; embolic devices for treating anomalies vasculature of the body; medical device, namely, arterial embolectomy device; medical device for embolization therapy in interventional radiology and oncology; embolic devices for interventional radiology, namely, interventional oncology and peripheral hemostasis; medical device for vascular embolization procedures; medical device used for embolization of vascular lesions, tumors, targeted arterial segments of hypervascular tumors, control of bleeding due to disease or trauma, organs and segmental embolizations; medical devices, namely, syringes and delivery catheters for the delivery of embolic agents delivered through a microcatheter under fluoroscopic control; medical apparatus, namely, system for vascular embolization procedures comprised primarily of microcatheters and applicators and also featuring hydrogel precursors | ACTIVE | Jul 1, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 19, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 19, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 12, 2023 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 11, 2023 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 10, 2023 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 10, 2023 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 3, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2023 | IUAF | USE AMENDMENT FILED | — |
| Aug 1, 2023 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 1, 2023 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Aug 1, 2023 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 1, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 30, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jan 30, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jan 30, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 3, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Aug 1, 2022 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Aug 1, 2022 | EXT1 | SOU EXTENSION 1 FILED | — |
| Aug 1, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Feb 1, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 3, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 3, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 3, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 11, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 22, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 14, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 18, 2021 | NWAP | NEW APPLICATION ENTERED | — |